Screening for cardiovascular safety: a structure-activity approach for guiding lead selection of melanin concentrating hormone receptor 1 antagonists.
暂无分享,去创建一个
Ju Gao | Anil Vasudevan | John K Lynch | Gang Zhao | A. Vasudevan | A. Souers | J. Segreti | H. Sham | R. Fryer | K. Marsh | P. Kym | B. Dayton | Andrew J Souers | Brian D Dayton | Kennan C Marsh | Hing L Sham | Christine A Collins | Philip R Kym | R. Reilly | S. Wagaw | J. Napier | Dariusz Wodka | Andrew S Judd | Mathew Mulhern | Sevan Brodjian | S. Brodjian | G. Reinhart | J. Polakowski | James J Napier | A. Judd | Regina M Reilly | Jason A Segreti | R. Iyengar | Jennifer C Freeman | Seble H Wagaw | Mathew M. Mulhern | Rajesh Iyengar | Glenn A Reinhart | Lee C Preusser | Lisa Hernandez | James S Polakowski | Thomas J Campbell | Ryan M Fryer | L. Hernandez | J. Lynch | L. Preusser | Ju Gao | Gang Zhao | J. Freeman | D. Wódka | T. J. Campbell | C. A. Collins